Allocca Biotechnology Inc is categorized under Medical Research in Huntington, NY and active since 1999.
Allocca Biotechnology Inc was established in 1999, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Medical Research business, which does work in the B2B market, and is classified as a Medical Research, under code number 6213992 by the NAICS.
If you are seeking more information, feel free to contact John Alloca, Owner at the company’s single location by writing to 202 East Main St # 102, Huntington, New York NY 11743 or by phoning (631) 757-3919. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Allocca Biotechnology Inc |
| Contact Person: | John Alloca, Owner |
| Address: | 202 East Main St # 102, Huntington, New York 11743 |
| Phone Number: | (631) 757-3919 |
| Website Address: | allocca.com |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 1999 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Medical Research |
| SIC Code: | 8733 |
| NAICS Code: | 6213992 |
| Share This Business: |
Allocca Biotechnology Inc was started in 1999 to provide professional Medical Research under the SIC code 8733 and NAICS code 6213992. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact John Alloca, Owner for inquiries that concern Allocca Biotechnology Inc by calling the company number (631) 757-3919, as your correspondence is most welcome. Additionally, the physical location of the single location of Allocca Biotechnology Inc can be found at the coordinates 40.8811,-73.39639 as well as the street address 202 East Main St # 102 in Huntington, New York 11743.
For its online presence, you may visit Allocca Biotechnology Inc’s website at allocca.com and engage with its social media outlets through on Twitter and on Facebook.